Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06096272 · ClinicalTrials.gov registry record · NA
Using Augmented Reality to Promote Physical Activity in Children With Cerebral Palsy
A NA study of Cerebral Palsy and Physical Inactivity, sponsored by Children's Hospital Los Angeles.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT06096272: Recruiting NA study of Cerebral Palsy and Physical Inactivity, sponsored by Children's Hospital Los Angeles.
NCT06096272 is a NA study of Cerebral Palsy and Physical Inactivity that is actively recruiting participants, run by Children's Hospital Los Angeles. The registered enrollment target is 30 participants, below the 229-participant average among 91 other Cerebral Palsy trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06096272, a NA study of Cerebral Palsy and Physical Inactivity, is actively recruiting participants, sponsored by Children's Hospital Los Angeles.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
Children with cerebral palsy (CP), Gross Motor Functional Classification Scale (GMFCS) I-II will be recruited to participate in a home based physical activity intervention for 4 weeks. Demographic data will be collected, and validated surveys assessing baseline physical activity level and mobility will be completed. Participants will have an exercise program assigned and will be given a logbook to record their exercise adherence. They will be assigned to the Augment Reality (AR) app group. The AR app group will have exercises administered through the AR app. At the end of the program, participants will complete final surveys and an exit interview.
Primary Outcome
Measured by proportion of time in the mobile application (180/360 total minutes).
Conditions Studied
Interventions
- DEVICE Augment Reality Exergames
Study Locations (1)
California
- Jackie and Gene Autry Orthopedic Center, CHLA - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2024-06-07 |
| Est. Completion | 2025-09-01 |
| Phase | NA |
What NCT06096272 shows while recruiting
NCT06096272 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 229-participant average among 91 other Cerebral Palsy trials with a reported enrollment target (87% lower).
The record links to 5 conditions, with Cerebral Palsy appearing as the primary indexed condition, and to 1 intervention - of which Augment Reality Exergames is the first listed.
NCT06096272 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06096272 about?
NCT06096272 is a clinical study titled "Using Augmented Reality to Promote Physical Activity in Children With Cerebral Palsy". Children with cerebral palsy (CP), Gross Motor Functional Classification Scale (GMFCS) I-II will be recruited to participate in a home based physical activity intervention for 4 weeks. Demographic data will be collected, and validated surveys assessing baseline physical activity level and mobility w...
What is the current status of trial NCT06096272?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2024-06-07. Estimated completion is 2025-09-01.
What conditions does trial NCT06096272 study?
This clinical trial studies the following conditions: Cerebral Palsy, Physical Inactivity, Pediatric ALL, Physical Disability, Mobile Phone Use.
What interventions are being tested in trial NCT06096272?
The interventions under investigation include: Augment Reality Exergames (DEVICE).
Who is sponsoring clinical trial NCT06096272?
This trial is sponsored by Children's Hospital Los Angeles, which has 119 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06096272 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cerebral Palsy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06096272's enrollment target sits among peer trials
30 55th of 91 higher than 29 of 91 other Cerebral Palsy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cerebral Palsy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Motor Training for Infants With Cerebral Palsy
RECRUITING · NA
-
Implementation of Therapy Together
RECRUITING · NA
-
Evaluating Long-term Use of a Pediatric Robotic Exoskeleton (P.REX/Agilik) to Improve Gait in Children With Movement Disorders
RECRUITING · NA
-
Em-power: Maximizing Functional Independence for Children With Severe Cerebral Palsy
RECRUITING · NA
-
Neuromodulation of the Cortex and Spinal Cord
RECRUITING · NA
-
Effectiveness of Robotic Gait Training and Physical Therapy for Children and Youth With Cerebral Palsy
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI